Delivery Order SPE2DR25D1103-SPE2DR26FE232
- Not listed
- The Defense Logistics Agency awarded a $4,788.94 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Xulane 150-35 mcg/day patches (three-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xulane is a contraceptive transdermal patch, representing a routine pharmaceutical procurement through the...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $1,127.12 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-count) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed price, competitively awarded delivery order represents a routine pharmaceutical supply transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $10,516.82 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (3-pack) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract requires delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among eligible contractors in the open market. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,350.31 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (3-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xulane is a transdermal contraceptive patch used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $22,572.33 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. XULANE is a combination hormonal contraceptive patch used for birth...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.36 for Xulane 150-35 mcg/day transdermal patches (3-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award conditions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.48 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY transdermal patches (3-count package) on December 11, 2025, with completion scheduled for December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XULANE is a contraceptive patch containing norgestimate and ethinyl estradiol,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-pack units) with a ceiling value of $1,053.04. This delivery order, which carries a firm fixed price structure and no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.44 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count units) on October 30, 2025, with completion by October 31, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical supplier to...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE232Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,862.46 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3 units) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. Xulane is a contraceptive transdermal patch that provides hormonal birth control through norelgestromin and ethinyl estradiol delivery. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, regularly supplies military and veteran healthcare systems with medications, vaccines, and medical devices through its DLA contracts. This delivery order exemplifies the company's role as a prime vendor supporting the Defense Health Agency and broader Department of Defense medical supply chain requirements. The IDC vehicle enables AmerisourceBergen to fulfill diverse pharmaceutical procurement needs across multiple therapeutic domains for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/4/25 |